NEW YORK, NY--(Marketwire - April 20, 2010) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO®) on Unilife Corp. (
Unilife Corp. ("Unilife" or "the Company") develops and supplies innovative safety medical devices for pharmaceutical and healthcare markets that mandate the use of safety sharps. The Company is progressively launching its patented portfolio of prefilled and clinical syringes under two brands: (1) Unifill™, a glass-barreled, prefilled safety syringe; and (2) Unitract™, a line of plastic-barreled, clinical safety syringes.
The distinctive feature of Unilife's products is that needle retraction is both automatic and operator controlled within a fully integrated syringe -- a combination of safety features that Unilife does not believe is available in any other technology marketed today. The Company's syringes may virtually eliminate the risk of acquiring bloodborne infections, such as HIV or hepatitis C, via needlestick injuries or blood splatter. Unilife holds ISO 13485 certifications with FDA-registered manufacturing facilities in Pennsylvania.
Importantly, sanofi-aventis SA (
About Crystal Research Associates, LLC
Crystal Research Associates, LLC is an independent research firm that provides institutional-quality, fee-based research to small- and mid-cap companies. Crystal Research Associates' unique and novel product, the Executive Informational Overview® (EIO®), is free of investment ratings, target prices, and forward-looking financial models. The EIO® presents a crystal clear, detailed report on a company (public or private) in a manner that is easily understood by the Wall Street financial community. The EIO® details a company's product/technology/service offerings, market size(s), key intellectual property, leadership, growth strategy, competition, risks, financial statements, key events, and other such fundamental information. Crystal Research Associates has offices in New York City, West Palm Beach, Montréal, and Toronto. Crystal Research Associates has been compensated by Unilife Corp. in cash of twenty-five thousand U.S. dollars and eighteen thousand seven hundred fifty Warrants in 2009 to purchase Unilife stock for its services in creating this report, for updates, and for printing costs.
Forward-Looking Safe Harbor Statement
Statements in this news release regarding future financial and operating results, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements including limited operating history, need for future capital, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic reports, including forms filed with the SEC.
These statements, and other forward-looking statements, are not guarantees of future performance and involve risks and uncertainties. Crystal Research Associates assumes no obligation to update any of the forward-looking statements in this release.
Contact Information:
Contact:
Jeffrey J. Kraws/Karen B. Goldfarb
Crystal Research Associates, LLC
P: (609) 306-2274, F: (609) 395-9339